Access this content
Your content has been opened.
Rapid Development of an Amorphous Solid Dispersion (ASD) – Nifedipine (NIF) has been emailed to . Entered the wrong email?
Don't see the content in your inbox?
Make sure to check your spam and other messages folders.
Can't get to your email right now?
Please enter a valid verification code.
Code sent to:
Register to access this content
By accessing content on the Pharmaceutical Manufacturing Resource Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.
Amorphous solid dispersions (ASD) have long been used to increase the solubility and bio-availability of poorly-soluble compounds. A considerable amount of research has been car-ried out and has generated useful techniques in the area of ASD development. Surprisingly, the number of examples with successful application of the available techniques has been meager. Herein, a case study with nifedipine is presented where ASD candidates were rap-idly determined within 2-3 weeks by utilizing a compilation of these techniques. Keywords: Amorphous Solid Dispersion (ASD), Spray Drying, Crystallization, Solubility, Sta-bility, Dissolution